Arcus Biosciences RCUS Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's common stock, shares, outstanding?
- Arcus Biosciences (RCUS) reported common stock, shares, outstanding of $125.5M in Q1 2026.
- How has Arcus Biosciences's common stock, shares, outstanding changed year-over-year?
- Arcus Biosciences's common stock, shares, outstanding increased by 18.5% year-over-year, from $105.9M to $125.5M.
- What is the long-term trend for Arcus Biosciences's common stock, shares, outstanding?
- Over 3 years (2022 to 2025), Arcus Biosciences's common stock, shares, outstanding has grown at a 19.8% compound annual growth rate (CAGR), from $72.9M to $125.3M.